Rethinking <scp>HIV</scp> treatment: How non‐<scp>integrase strand</scp> regimens may hold the key to better immune health
This study challenges the assumption that INSTI-based ARV regimens are universally superior, suggesting that non-INSTI therapies may better preserve immune function by reducing PD-1 expression. These findings highlight the potential benefits of non-INSTI regimens in improving long-term clinical outcomes in HIV treatment, warranting further research.
Authors
- Miłosz Parczewski (ORCID: https://orcid.org/0000-0003-1869-1084)
- Kaja Scheibe (ORCID: https://orcid.org/0000-0001-5951-9067)
- Karolina Skonieczna‐Żydecka (ORCID: https://orcid.org/0000-0002-3430-9079)
- Paulina Niedźwiedzka‐Rystwej (ORCID: https://orcid.org/0000-0003-4065-3842)
- Rafał Hrynkiewicz (ORCID: https://orcid.org/0000-0002-0688-6928)
- Karol Serwin (ORCID: https://orcid.org/0000-0002-1071-8337)
- Filip Lewandowski (ORCID: https://orcid.org/0009-0002-5986-5845)
- Bogusz Aksak‐Wąs (ORCID: https://orcid.org/0000-0003-2092-3737)
- Franciszek Lenkiewicz
Institutions
- University of Szczecin (PL)
- Pomeranian Medical University (PL)
Publication Details
- Journal
- HIV Medicine
- Published
- 2025-03-28
- DOI
- https://doi.org/10.1111/hiv.70020
- Citations
- 1
- Primary Topic
- HIV-related health complications and treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.25